Marie‐Anne Valentin

Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study

Elisabeth H. Thijssen, Renaud La Joie, Amelia Strom et al. · The Lancet Neurology · 2021 · 592 citations · Full text

Life Sciences, Neurology, Neuroscience +16

β-Defensin 2 is a responsive biomarker of IL-17A–driven skin pathology in patients with psoriasis

Frank Kolbinger, Christian Loesche, Marie‐Anne Valentin et al. · Journal of Allergy and Clinical Immunology · 2016 · 234 citations · Full text

Medicine, Dermatology, Immunology +17

Treatment of primary Sjögren's syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity

Thomas Dörner, Maximilian Posch, Yue Li et al. · Annals of the Rheumatic Diseases · 2019 · 200 citations

Life Sciences, Immunology, Pharmacology +17

Validation of immunoassay for protein biomarkers: Bioanalytical study plan implementation to support pre-clinical and clinical studies

Marie‐Anne Valentin, Shenglin Ma, An Sha Zhao et al. · Journal of Pharmaceutical and Biomedical Analysis · 2011 · 145 citations

Pharmacy, Clinical Sciences, Proteomics +13

Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study

Benjamin A. Fisher, Antónia Szántó, Wan‐Fai Ng et al. · The Lancet Rheumatology · 2020 · 126 citations

Life Sciences, Clinical Sciences, Immunology +14